NZ521241A - Azole compounds as therapeutic agents for fungal infections - Google Patents

Azole compounds as therapeutic agents for fungal infections

Info

Publication number
NZ521241A
NZ521241A NZ521241A NZ52124101A NZ521241A NZ 521241 A NZ521241 A NZ 521241A NZ 521241 A NZ521241 A NZ 521241A NZ 52124101 A NZ52124101 A NZ 52124101A NZ 521241 A NZ521241 A NZ 521241A
Authority
NZ
New Zealand
Prior art keywords
hydroxy
phenyl
compound
triazolone
difluorophenyl
Prior art date
Application number
NZ521241A
Other languages
English (en)
Inventor
Ashwani Kumar Verma
Sudershan K Arora
Jasbir Singh Arora
Ashock Rattan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN198DE2000 external-priority patent/IN191188B/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to NZ530614A priority Critical patent/NZ530614A/en
Priority to NZ530613A priority patent/NZ530613A/en
Publication of NZ521241A publication Critical patent/NZ521241A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ521241A 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections NZ521241A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ530614A NZ530614A (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections
NZ530613A NZ530613A (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN198DE2000 IN191188B (xx) 2000-03-07 2000-03-07
US09/575,578 US6670363B1 (en) 2000-03-07 2000-05-22 Azole compounds as therapeutic agents for fungal infections
PCT/IB2001/000300 WO2001066551A2 (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Publications (1)

Publication Number Publication Date
NZ521241A true NZ521241A (en) 2004-02-27

Family

ID=26324879

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ521241A NZ521241A (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Country Status (8)

Country Link
EP (1) EP1278755A2 (xx)
JP (1) JP2004501867A (xx)
AU (1) AU3402301A (xx)
CA (1) CA2402345A1 (xx)
NZ (1) NZ521241A (xx)
PL (1) PL365072A1 (xx)
RU (1) RU2002126272A (xx)
WO (1) WO2001066551A2 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002044160A1 (fr) * 2000-11-30 2002-06-06 Senju Pharmaceutical Co., Ltd. Medicaments pour lutter contre la pancreatite et produits medicinaux pour prevenir et traiter l'oesophagite peptique
EP1347758A1 (en) 2000-12-26 2003-10-01 Ranbaxy Laboratories, Ltd. Azole compounds as anti-fungals agents
WO2002060446A1 (en) 2001-01-29 2002-08-08 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
IN192526B (xx) * 2001-09-25 2004-04-24 Ranbaxy Lab
AU2002328176A1 (en) * 2002-08-26 2004-03-11 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
JPWO2007020888A1 (ja) 2005-08-12 2009-02-26 武田薬品工業株式会社 脳・神経細胞保護剤および睡眠障害治療薬
US9156830B2 (en) 2011-05-17 2015-10-13 Shionogi & Co., Ltd. Heterocyclic compounds
AU2012272804B2 (en) 2011-06-22 2017-07-06 Vyome Therapeutics Limited Conjugate-based antifungal and antibacterial prodrugs
CN102617494B (zh) * 2012-03-15 2014-10-29 南京工业大学 一种含有烯醚结构的三唑类化合物及其制备方法和用途
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
BR112016017690A2 (pt) 2014-01-29 2017-08-08 Vyome Biosciences Pvt Ltd Tratamentos para acne resistente
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
AR109545A1 (es) 2016-09-29 2018-12-19 Bayer Cropscience Ag Derivados de triazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218017B (xx) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Also Published As

Publication number Publication date
AU3402301A (en) 2001-09-17
PL365072A1 (en) 2004-12-27
WO2001066551A8 (en) 2003-06-26
WO2001066551A2 (en) 2001-09-13
RU2002126272A (ru) 2004-08-10
CA2402345A1 (en) 2001-09-13
WO2001066551A3 (en) 2002-03-07
JP2004501867A (ja) 2004-01-22
EP1278755A2 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
US5371101A (en) Azole compounds, their production and use
CA2680292C (en) Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
Hashemi et al. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents
NZ521241A (en) Azole compounds as therapeutic agents for fungal infections
US7189858B2 (en) N-phenyl substituted carbamoyloxyalkyl-azolium derivatives
AU678278B2 (en) Azole compounds, their production and use
KR100572996B1 (ko) 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
FI62836C (fi) Foerfarande foer framstaellning av heterocykliska derivat av bakterier och svampar foerstoerande 1-(1,3-dioxolan-2-ylmetyl)-1h-imidazoler och -1h-1,2,4-triazoler
KR100593395B1 (ko) 광범위-스펙트럼 항진균제로서의 수용성 아졸
US6362206B1 (en) Azole compounds, their production and use
IE56055B1 (en) Triazole antifungal agents
EP0115400B1 (en) Triazole antifungal agents
JPH0649033A (ja) 光学活性アゾール化合物およびその用途
US6670363B1 (en) Azole compounds as therapeutic agents for fungal infections
AU740324B2 (en) New triazoles as therapeutic agents for fungal infections
NZ530613A (en) Azole compounds as therapeutic agents for fungal infections
KR19980024429A (ko) 엔-벤질아졸륨 유도체
DK157998B (da) 1-(1,2,4-triazol-1-yl)-3-(5-trifluormethylimidazol-1-yl)propan-2-ol-forbindelser og farmaceutisk og landbrugsmaessigt acceptable salte deraf samt farmaceutisk praeparat og landbrugsfungicid indeholdende disse
US6153616A (en) Triazoles as therapeutic agents for fungal infections
EP1412337A1 (en) Azole compounds as anti-fungal agents
JPH08104676A (ja) アゾール化合物、その製造方法及び用途
IE48762B1 (en) Heterocyclic derivatives of(4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1h-imidazoles and 1h-1,2,4-triazoles,processes for preparing them and compositions containing them
WO2003087106A1 (en) Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)